Printer Friendly
The Free Library
21,607,446 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

St. Francis Medical Technologies' Interspinous Process Decompression X STOP Implant Recognized by BUPA.

ALAMEDA, California, August 29 /PRNewswire/ -- St. Francis Medical Technologies received approval of its procedure code in the UK, used to obtain reimbursement for its procedure to treat Lumbar Spinal Stenosis (LSS). After thorough analysis of all the available scientific and clinical data, including those of a prospective randomized multicenter study, BUPA BUPA n abbr (= British United Provident Association) → seguro médico privado , the leading private health care insurance provider in the UK has recognized this procedure for use on its members when performed by a consultant who has been specifically trained by St. Francis Medical Technologies. Based on the scientific proof of efficacy and the unique characteristics of the implant, the coding was issued by CCSD CCSD Clark County School District
CCSD Canadian Council on Social Development
CCSD Community Consolidated School District (Palatine, IL)
CCSD Cobb County School District (Georgia) 
, the UK private health sector coding party as a product specific code V5484 -- "Interspinous Process Decompression Interspinous Process Decompression, or IPD®, is a minimally invasive surgical procedure in which an implant is placed between the spinous processes of the symptomatic disc levels.  X STOP(R)."

Recognition of the procedure by BUPA represents an important milestone for the acceptance of St. Francis Medical Technologies' patented X STOP, an Interspinous Process Decompression (IPD) system that is a less invasive procedure used to treat and correct LSS, as a stand-alone alternative to decompressive surgery.

"Over 3,000 X STOP devices have been implanted in people worldwide," said Kevin Sidow, president and chief executive officer. "This code will expand availability of the procedure to a wider audience of LSS sufferers."

Physicians use the CCSD code to support the medical necessity of treating signs, symptoms, injuries, diseases and conditions associated with LSS.

X STOP is unique in the applied non-destructive surgical technique and product features, offering a minimally invasive, non-fusion alternative to decompressive surgery.

The X STOP is the first and only device that has been clinically proven to relieve the symptoms associated with spinal stenosis as a stand-alone surgical implant; this provides an alternative to treatments that involve standard decompression surgery, often augmented with spinal hardware.

About Lumbar Spine Stenosis

Acquired lumbar spinal stenosis is a degenerative narrowing of the spinal canal, nerve root canals and/or intervertebral foramina caused by bone and/or ligament hypertrophy in local, segmental or generalized regions. Alternative treatments include, medical management, epidural steroid injections and decompression laminectomy laminectomy /lam·i·nec·to·my/ (lam?i-nek´tah-me) excision of the posterior arch of a vertebra.

lam·i·nec·to·my
n.
Excision of a vertebral lamina. Also called rachiotomy.
 with or without fusion.

About St. Francis Medical Technologies

St. Francis Medical Technologies is a privately held company privately held company

A firm whose shares are held within a relatively small circle of owners and are not traded publicly.
 based in San Francisco, Calif. The company is engaged in the discovery, development, manufacturing and marketing of novel treatments for degenerative spinal disorders worldwide.

    SFMT Contact:
    Tel: +1-510-530-9267 | Fax: +1-510-337-2698
    www.sfmt.com | Info@sfmt.com



About SFMT SFMT San Francisco Mime Troupe (San Francisco, CA)
SFMT SIMD-oriented Fast Mersenne Twister
 Europe B.V.

St. Francis Medical Technologies received CE mark for the X STOP in July, 2002, and created a subsidiary based in the Netherlands. Currently the product is being distributed in Europe, Australia, New Zealand, South Africa, and Turkey.

    SFMT B.V. contact:
    Tel: +31-343-523-890 | Fax: +31-343-523-891
    For the UK Toll-free: Tel: +0800-0-144-155 | Fax: +0800-0-144-156
    www.sfmt.com | info@sfmteurope.com



Web site: http://www.sfmt.com

media, Lex Giltaij of St. Francis Medical Technologies, +31-343-523-890
COPYRIGHT 2005 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire Europe
Date:Aug 29, 2005
Words:471
Previous Article:DiBcom Raises EUR 24.5M Round to Extend Mobile TV Leadership.
Next Article:Fairies From Never Land Arrive At Disneyland.



Related Articles
St. Francis Medical Technologies Names New Chief Executive.
St. Francis Medical Technologies, Inc. Disagrees With FDA Advisory Panel's Recommendation Regarding X STOP(R).
St. Francis Medical Technologies, Inc. Receives FDA Letter for X STOP(R).
St. Francis Medical Technologies Appoints Michael Bates CFO; Former Silicon Genetics CFO Joints St. Francis.
St. Francis Medical Technologies (SFMT) Europe Appoints Keith Summerhayes Director Clinical & Regulatory Affairs.
Kyphon Closes Acquisition of St. Francis Medical Technologies.
Video: Kyphon and the X-STOP(R) Procedure to be Featured on American Health Radio on Monday, April 2, 2007.
Video: Kyphon and the X-STOP(R) Procedure to be Featured on American Health Radio on Monday, April 2, 2007.

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles